EUVIMED · CrossrefZeitschrift
Pharmaceutical Medicine
ISSN 1178-2595 · Springer Science and Business Media LLC
Neueste Artikel
Perceptions of Australian Medical Affairs and Cross-Functional Participants on the Role of Medical Affairs in Quality Use of Medicines (QUM)
Regulatory Pathways and Pivotal Trial Characteristics of Medicines Designated under the European Medicines Agency’s Priority Medicines Scheme Approved between 2018 and 2024
Eight Hallmarks for Governing Artificial Intelligence in Medical Affairs: A Structured Pathway for Responsible AI Adoption
From Invisible to Enrolled: How Artificial Intelligence Is Reshaping Clinical Trial Recruitment
Development of a Competency Framework for Medical Affairs Professionals in Australasia
The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022
Professional Competencies and Capabilities in the Development of Medicines
Artificial Intelligence: Applications in Pharmacovigilance Signal Management
Disproportionality Analysis and Causal Inference in Drug Safety
Transdermal Drug Delivery Systems: Different Generations and Dermatokinetic Assessment of Drug Concentration in Skin
Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities
How Can General Managers Best Leverage Medical Affairs Now and in the Future?
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials
The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results
The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations
The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies
Tackling Counterfeit Drugs: The Challenges and Possibilities
Real-World Evidence: A Primer
Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets
Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond
Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument
Delivery Strategies for mRNA Vaccines
Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic
Biosimilar Uptake: The Importance of Healthcare Provider Education
Customer Centricity in Medical Affairs Needs Human-centric Artificial Intelligence
Developing Medical Affairs Leaders Who Create the Future
EUVIMED